Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial
Anand V. Kulkarni, Mahathi Avadhanam, Puja Karandikar, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 5, pp. 864-874
Closed Access | Times Cited: 17

Showing 17 citing articles:

Acute liver failure
Rakhi Maiwall, Anand V. Kulkarni, Juan Pablo Arab, et al.
The Lancet (2024) Vol. 404, Iss. 10454, pp. 789-802
Closed Access | Times Cited: 24
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Ashok Choudhury, Anand V. Kulkarni, Vinod Arora, et al.
Hepatology International (2025) Vol. 19, Iss. 1, pp. 1-69
Open Access | Times Cited: 2
The challenges and potential of microRNA-based therapy for patients with liver failure syndromes and hepatocellular carcinoma
Oliver Tavabie, Albert Salehi, Varuna Aluvihare
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 3, pp. 179-191
Closed Access | Times Cited: 4
Critical care management of acute liver failure
Surender Singh Sehrawat, Madhumita Premkumar
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 2, pp. 361-376
Closed Access | Times Cited: 4
Review article: Evaluation and care of the critically ill patient with cirrhosis
Iva Košuta, Madhumita Premkumar, K. Rajender Reddy
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 12, pp. 1489-1509
Closed Access | Times Cited: 4
Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis
Zhaohui Bai, Congcong Li, Yongjie Lai, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 287-287
Open Access
Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit
Marika Rudler, Marie de Matharel, Charlotte Bouzbib, et al.
United European Gastroenterology Journal (2025)
Open Access
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure
Julian Pohl, Dimitrios Aretakis, Frank Tacke, et al.
Seminars in Liver Disease (2025)
Closed Access
Decompensated cirrhosis: an update of the BSG/BASL admission care bundle
Stuart McPherson, Nadir Abbas, Michael Allison, et al.
Frontline Gastroenterology (2025), pp. flgastro-103074
Closed Access
Hepatic encephalopathy in cirrhosis: therapies and developments
Ajay Kumar Mishra, Radha K. Dhiman
Metabolic Brain Disease (2025) Vol. 40, Iss. 5
Closed Access
Novel therapeutic effects of rifaximin in combination with methylprednisolone for LPS-induced ‎oxidative stress and inflammation in mice‎: ‎an in vivo study
Marwa Salih Al-Naimi, Ahmed R. Abu‐Raghif, Hayder Adnan Fawzi
Toxicology Reports (2024) Vol. 13, pp. 101808-101808
Open Access | Times Cited: 3
Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?
Chien‐Hao Huang, Piero Amodio
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 115-119
Open Access | Times Cited: 2
Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota
Siyuan Sun, Guangheng Zhang, Shimeng Lv, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Antimicrobial Resistance in Cirrhosis
Vinay Jahagirdar, Mohammed Habeeb, Anand V. Kulkarni
Current Hepatology Reports (2024) Vol. 23, Iss. 3, pp. 423-434
Closed Access | Times Cited: 1
Management der hepatischen Enzephalopathie bei Patienten mit akut-auf-chronischem Leberversagen
Christian Labenz
Deleted Journal (2024) Vol. 19, Iss. 4, pp. 347-354
Closed Access
Short-Term Primary Rifaximin Prophylaxis Has No Beneficial Role in Patients With Cirrhosis
Sai Spoorthy Penumarthi, Bhavani Lalkota, Shivani Jangili, et al.
American Journal of Therapeutics (2024) Vol. 32, Iss. 1, pp. e81-e84
Closed Access
Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy
Lorenzo Ridola, Antonio Marí
World Journal of Hepatology (2024) Vol. 16, Iss. 11, pp. 1356-1360
Closed Access
Page 1

Scroll to top